Characterization and functional analysis of extracellular vesicles and muscle-abundant miRNAs (miR-1, miR-133a, and miR-206) in C2 C12 myocytes and mdx Mice

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Matsuzaka, Yasunari ^a   Tanihata, Jun ^a   Komaki, Hirofumi ^b   Ishiyama, Akihiko ^b   Oya, Yasushi ^b   Rüegg, Urs ^c   Takeda, Shin Ichi ^a   Hashido, Kazuo ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3,3' (1,4 PHENYLENE)BIS[N [4 (4,5 DIHYDRO 1H IMIDAZOL 2 YL)PHENYL]ACRYLAMIDE]; CALCIUM ION; CD63 ANTIGEN; CERAMIDE; CREATINE KINASE; EVANS BLUE; MESSENGER RNA; MICRORNA 1; MICRORNA 133A; MICRORNA 206; UNCLASSIFIED DRUG; MICRORNA; MIRN133 MICRORNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C2C12 CELL LINE; CELL CULTURE; CELL DEATH; CELL FUNCTION; CELL LINE; CELL STRESS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DUCHENNE MUSCULAR DYSTROPHY; ENZYME BLOOD LEVEL; EXOSOME; GENE OVEREXPRESSION; HUMAN; IN VIVO STUDY; MALE; MOUSE; MUSCLE CELL; MUSCLE REGENERATION; MYOTUBE; NONHUMAN; RNA ANALYSIS; SERUM; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; ANIMAL; METABOLISM; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CELL LINE; EXTRACELLULAR VESICLES; MICE; MICE, INBRED MDX; MICRORNAS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 85006386997     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0167811     Document Type: Article

References (66)

1. Durbeej M, Campbell KP. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev. 2002; 12:349-361. PMID: 12076680
2. Takeshima Y, Yagi M, Okizuka Y, Awano H, Zhang Z, Yamauchi Y, et al. Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center. J Hum Genet. 2010; 55:379-388. doi: 10.1038/jhg.2010.49 PMID: 20485447
3. Sultan A, Fayaz M. Prevalence of cardiomyopathy in Duchenne and Becker's muscular dystrophy. J Ayub Med Coll Abbottabad. 2008; 20(2):7-13. PMID: 19385447
4. Malm C, Sjödin TL, Sjöberg B, Lenkei R, Renström P, Lundberg I, et al. Leukocytes, cytokines, growth factors and hormones in human skeletal muscle and blood after uphill or downhill running. J Physiol. 2004; 556:983-1000. doi: 10.1113/jphysiol.2003.056598 PMID: 14766942
5. Zatz M, Rapaport D, Vainzof M, Passos-Bueno MR, Bortolini ER, Pavanello Rde C, et al. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy. J Neurol Sci. 1991; 102(2):190-196. PMID: 2072118
6. Lee S, Vasudevan S. Post-transcriptional stimulation of gene expression by microRNAs. Adv Exp Med Biol. 2013; 768:97-126. doi: 10.1007/978-1-4614-5107-5-7 PMID: 23224967
7. ∅rom UA, Nielsen FC, Lund AH. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell. 2008; 30:460-471. doi: 10.1016/j.molcel.2008.05.001 PMID: 18498749
8. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. doi: 10.1038/nrg2843 PMID: 20661255
9. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011; 108(12):5003-5008. doi: 10.1073/pnas.1019055108 PMID: 21383194
10. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating micro-RNA. Nucleic Acids Res. 2011; 39(16):7223-7233. doi: 10.1093/nar/gkr254 PMID: 21609964
11. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011; 13(4):423-433. doi: 10.1038/ncb2210 PMID: 21423178
12. Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010; 38(20):7248-7259. doi: 10.1093/nar/gkq601 PMID: 20615901
13. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6):654-659. doi: 10.1038/ncb1596 PMID: 17486113
14. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-1476. doi: 10.1038/ncb1800 PMID: 19011622
15. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009; 2(100): ra81. doi: 10.1126/scisignal.2000610 PMID: 19996457
16. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A. 2010; 107(14):6328-6333. doi: 10.1073/pnas.0914843107 PMID: 20304794
17. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006; 20(5):847-856. doi: 10.1038/sj.leu.2404132 PMID: 16453000
18. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood. 2007; 110(7):2440-2448. doi: 10.1182/blood-2007-03-078709 PMID: 17536014
19. Zhu H, Fan GC. Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am J Cardiovasc Dis. 2011; 1:138-149. PMID: 22059153
20. Hu G, Drescher KM, Chen XM. Exosomal miRNAs: Biological Properties and Therapeutic Potential. Front Genet. 2012; 3:56. doi: 10.3389/fgene.2012.00056 PMID: 22529849
21. Ge Q, Zhou Y, Lu J, Bai Y, Xie X, Lu Z. miRNA in plasma exosome is stable under different storage conditions. Molecules. 2014; 19(2):1568-1575. doi: 10.3390/molecules19021568 PMID: 24473213
22. Cacchiarelli D, Legnini I, Martone J, Cazzella V, D'Amico A, Bertini E, et al. miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med. 2011; 3:258-265. doi: 10.1002/emmm. 201100133 PMID: 21425469
23. Mizuno H, Nakamura A, Aoki Y, Ito N, Kishi S, Yamamoto K, et al. Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One. 2011; 6:e18388. doi: 10.1371/journal.pone.0018388 PMID: 21479190
24. Li X, Li Y, Zhao L, Zhang D, Yao X, Zhang H, et al. Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients. Mol Ther Nucleic Acids. 22 2014; e177.
25. Matsuzaka Y, Kishi S, Aoki Y, Komaki H, Oya Y, Takeda S, et al. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy. Environ Health Prev Med. 2014; 19:452-458. doi: 10.1007/ s12199-014-0405-7 PMID: 25150707
26. Roberts TC, Blomberg KE, McClorey G, El Andaloussi S, Godfrey C, Betts C, et al. Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy. Mol Ther Nucleic Acids. 2012; 14:e39.
27. Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, Morlando M, et al. MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab. 2010; 12:341-351. doi: 10.1016/j.cmet.2010.07.008 PMID: 20727829
28. Cazzella V, Martone J, Pinnarò C, Santini T, Twayana SS, Sthandier O, et al. Exon 45 skipping through U1-snRNA antisense molecules recovers the Dys-nNOS pathway and muscle differentiation in human DMD myoblasts. Mol Ther. 2012; 20(11):2134-2142. doi: 10.1038/mt.2012.178 PMID: 22968481
29. Güller I, Russell AP. MicroRNAs in skeletal muscle: their role and regulation in development, disease and function. J Physiol. 2010; 588:4075-4087. doi: 10.1113/jphysiol.2010.194175 PMID: 20724363
30. Matsuzaka Y, Hashido K. Roles of miR-1, miR-133a, and miR-206 in calcium, oxidative stress, and NO signaling involved in muscle diseases. RNA & Disease. 2015; 2:e558.
31. Kosaka N, Iguchi H, Hagiwara K, Yoshioka Y, Takeshita F, Ochiya T. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem. 2013; 288:10849-59. doi: 10.1074/jbc.M112.446831 PMID: 23439645
32. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008; 319:1244-1247. doi: 10.1126/ science.1153124 PMID: 18309083
33. Kubota S, Chiba M, Watanabe M, Sakamoto M, Watanabe N. Secretion of small/microRNAs including miR-638 into extracellular spaces by sphingomyelin phosphodiesterase 3. Oncol Rep. 2015; 33(1):67-73. doi: 10.3892/or.2014.3605 PMID: 25394686
34. Singh R, Pochampally R, Watabe K, Lu Z, Mo YY. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol Cancer. 2014; 13:256. doi: 10.1186/1476-4598-13-256 PMID: 25428807
35. Mittelbrunn M, Gutiérrez-Vázquez C, Villarroya-Beltri C, González S, Sánchez-Cabo F, González MÁ, et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun. 2011; 2:282. doi: 10.1038/ncomms1285 PMID: 21505438
36. Savina A, Fader CM, Damiani MT, Colombo MI. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic. 2005; 6(2):131-143. doi: 10.1111/j.1600-0854.2004. 00257.x PMID: 15634213
37. Bodensteiner JB, Engel AG. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology. 1978; 28(5):439-446. PMID: 76996
38. Kajimoto T, Okada T, Miya S, Zhang L, Nakamura S. Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes. Nat Commun. 2013; 4:2712. doi: 10.1038/ncomms3712 PMID: 24231649
39. Savina A, Furlán M, Vidal M, Colombo MI. Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem. 2003; 278(22):20083-20090. doi: 10.1074/jbc.M301642200 PMID: 12639953
40. Tamai K, Tanaka N, Nakano T, Kakazu E, Kondo Y, Inoue J, et al. Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein. Biochem Biophys Res Commun. 2010; 399(3):384-90. doi: 10.1016/j.bbrc.2010.07.083 PMID: 20673754
41. Ekström EJ, Bergenfelz C, von Bülow V, Serifler F, Carlemalm E, Jönsson G, et al. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Mol Cancer. 2014; 13:88. doi: 10.1186/1476-4598-13-88 PMID: 24766647
42. Forterre A, Jalabert A, Berger E, Baudet M, Chikh K, Errazuriz E, et al. Proteomic analysis of C2C12 myoblast and myotube exosome-like vesicles: a new paradigm for myoblast-myotube cross talk? PLoS One. 2014; 9:e84153. doi: 10.1371/journal.pone.0084153 PMID: 24392111
43. Choi JS, Yoon HI, Lee KS, Choi YC, Yang SH, Kim IS, et al. Exosomes from differentiating human skeletal muscle cells trigger myogenesis of stem cells and provide biochemical cues for skeletal muscle regeneration. J Control Release. 2016; 222:107-115. doi: 10.1016/j.jconrel.2015.12.018 PMID: 26699421
44. Svensson KJ, Christianson HC, Wittrup A, Bourseau-Guilmain E, Lindqvist E, Svensson LM, et al. Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem. 2013; 288:17713-17724. doi: 10.1074/jbc.M112. 445403 PMID: 23653359
45. Roberts TC, Godfrey C, McClorey G, Vader P, Briggs D, Gardiner C, et al. Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. Nucleic Acids Res. 2013; 41(20):9500-9513. doi: 10.1093/nar/gkt724 PMID: 23945935
46. Lane RE, Korbie D, Anderson W, Vaidyanathan R, Trau M. Analysis of exosome purification methods using a model liposome system and tunable-resistive pulse sensing. Sci Rep. 2015; 5:7639. doi: 10. 1038/srep07639 PMID: 25559219
47. Zeringer E, Li M, Barta T, Schageman J, Pedersen KW, Neurauter A, et al., Methods for the extraction and RNA profiling of exosomes. World J Methodol. 2013; 3(1):11-18. doi: 10.5662/wjm.v3.i1.11 PMID: 25237619
48. Kim YK, Yeo J, Kim B, Ha M, Kim VN. Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells. Mol Cell. 2012; 46(6):893-895. doi: 10.1016/j.molcel. 2012.05.036 PMID: 22749402
49. Clarke CJ, Truong TG, Hannun YA. Role for neutral sphingomyelinase-2 in tumor necrosis factor alphastimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2. J Biol Chem. 2007; 282:1384-1396. doi: 10.1074/jbc.M609216200 PMID: 17085432
50. Shamseddine AA, Airola MV, Hannun YA. Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes. Adv Biol Regul. 2015; 57:24-41. doi: 10.1016/j.jbior.2014.10.002 PMID: 25465297
51. Levy M, Castillo SS, Goldkorn T. nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis. Biochem Biophys Res Commun. 2006; 344:900-905. doi: 10.1016/j.bbrc.2006.04. 013 PMID: 16631623
52. Clarke CJ, Hannun YA. Neutral sphingomyelinases and nSMase2: bridging the gaps. Biochim Biophys Acta. 2006; 1758:1893-1901. doi: 10.1016/j.bbamem.2006.06.025 PMID: 16938269
53. Izarra A, Moscoso I, Levent E, Cañón S, Cerrada I, Díez-Juan A, et al. miR-133a enhances the protective capacity of cardiac progenitors cells after myocardial infarction. Stem Cell Reports. 2014; 3:1029-1042. doi: 10.1016/j.stemcr.2014.10.010 PMID: 25465869
54. Deng Z, Chen JF, Wang DZ. Transgenic overexpression of miR-133a in skeletal muscle. BMC Musculoskelet Disord. 2011; 12:115. doi: 10.1186/1471-2474-12-115 PMID: 21615921
55. Drawnel FM, Wachten D, Molkentin JD, Maillet M, Aronsen JM, Swift F, et al. Mutual antagonism between IP3 RII and miRNA-133a regulates calcium signals and cardiac hypertrophy. J Cell Biol. 2012; 199:783-798. doi: 10.1083/jcb.201111095 PMID: 23166348
56. He B, Xiao J, Ren AJ, Zhang YF, Zhang H, Chen M, et al. Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci. 2011; 18:22. doi: 10.1186/1423-0127-18-22 PMID: 21406115
57. Wang L, Li X, Zhou Y, Shi H, Xu C, He H, et al. Downregulation of miR-133 via MAPK/ERK signaling pathway involved in nicotine-induced cardiomyocyte apoptosis. Naunyn Schmiedebergs Arch Pharmacol. 2014; 387:197-206. doi: 10.1007/s00210-013-0929-1 PMID: 24190542
58. Honda A, Abe S, Hiroki E, Honda H, Iwanuma O, Yanagisawa N, et al. Activation of caspase 3, 9, 12, and Bax in masseter muscle of mdx mice during necrosis. J Muscle Res Cell Motil. 2007; 28:243-247. doi: 10.1007/s10974-007-9122-9 PMID: 17952618
59. Mouisel E, Vignaud A, Hourdé C, Butler-Browne G, Ferry A. Muscle weakness and atrophy are associated with decreased regenerative capacity and changes in mTOR signaling in skeletal muscles of venerable (18-24-month-old) dystrophic mdx mice. Muscle Nerve. 2010; 41:809-818. doi: 10.1002/mus. 21624 PMID: 20151467
60. Dakhlallah D, Zhang J, Yu L, Marsh CB, Angelos MG, Khan M. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart. J Cardiovasc Pharmacol. 2015; 65(3):241-251. doi: 10.1097/FJC.0000000000000183 PMID: 25658461
61. Li AY, Yang Q, Yang K. miR-133a mediates the hypoxia-induced apoptosis by inhibiting TAGLN2 expression in cardiac myocytes. Mol Cell Biochem. 2015; 400(1-2):173-181. doi: 10.1007/s11010-014-2273-2 PMID: 25421410
62. Li S, Xiao FY, Shan PR, Su L, Chen DL, Ding JY, et al. Overexpression of microRNA-133a inhibits ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting DAPK2. J Hum Genet. 2015; 60 (11):709-716. doi: 10.1038/jhg.2015.96 PMID: 26334104
63. Mallouk N, Jacquemond V, Allard B. Elevated subsarcolemmal Ca2+ in mdx mouse skeletal muscle fibers detected with Ca2+-activated K+ channels. Proc Natl Acad Sci U S A. 2000; 97(9):4950-4955. PMID: 10781103
64. Robert V, Massimino ML, Tosello V, Marsault R, Cantini M, Sorrentino V, et al. Alteration in calcium handling at the subcellular level in mdx myotubes. J Biol Chem. 2001; 276(7):4647-4651. doi: 10.1074/ jbc.M006337200 PMID: 11029464
65. Vandebrouck C, Martin D, Colson-Van Schoor M, Debaix H, Gailly P. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers. J Cell Biol. 2002; 158(6):1089-1096. doi: 10.1083/jcb.200203091 PMID: 12235126
66. Nakasa T, Ishikawa M, Shi M, Shibuya H, Adachi N, Ochi M. Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model. J Cell Mol Med. 2010; 14:2495-2505. doi: 10.1111/j.1582-4934.2009.00898.x PMID: 19754672